Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramsay Health CareASX:RHC +0.95%80 Intrinsic Value: Projected FCF is A$43.83 as of Sep. 06, 2026. GuruFocus rates ASX:RHC with a GF Score™ of 80/100 and a GF Value™ of A$40.77 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 342 Healthcare Providers & Services companies, Ramsay Health Care ranks worse than 54.09% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2026-09-06), Ramsay Health Care's Intrinsic Value: Projected FCF is A$43.83. The stock price of Ramsay Health Care is A$52.29. Therefore, Ramsay Health Care's Price-to-Intrinsic-Value-Projected-FCF of today is 1.2.
The historical rank and industry rank for Ramsay Health Care's Intrinsic Value: Projected FCF or its related term are showing as below:
ASX:RHC'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.87 Med: 1.55 Max: 2.46
Current: 1.19
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Ramsay Health Care was 2.46. The lowest was 0.87. And the median was 1.55.
ASX:RHC's Price-to-Projected-FCF is ranked worse than 54.09% of 342
companies
in the Healthcare Providers & Services industry
Industry Median: 1.075
vs ASX:RHC: 1.19
Ramsay Health Care (ASX:RHC) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Ramsay Health Care's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
52.29
/
43.825232031992
=
1.19
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Health Care Intrinsic Value: Projected FCF Related Terms
Ramsay Health Care Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Ramsay Health Care's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Health Care Intrinsic Value: Projected FCF Chart
ASX:RHC vs HCA, THC, EHC: Intrinsic Value: Projected FCF Comparison
For the Medical Care Facilities subindustry, Ramsay Health Care's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Health Care Price-to-Projected-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Health Care's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Ramsay Health Care's Price-to-Projected-FCF falls into.
Ramsay Health Care Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of A$43.83 mean?
Ramsay Health Care (ASX:RHC) has a Intrinsic Value: Projected FCF of A$43.83 as of Sep. 06, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Ramsay Health Care and its competitors. According to the industry distribution chart, Ramsay Health Care ranks #185 out of 342 companies in the Healthcare Providers & Services industry, placing it in the top 54.1%.
Is Ramsay Health Care's Intrinsic Value: Projected FCF too high?
Ramsay Health Care's current Intrinsic Value: Projected FCF is A$43.83. Based on the distribution chart, Ramsay Health Care ranks #185 out of 342 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ramsay Health Care has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's Intrinsic Value: Projected FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Health Care ranks #185 out of 342 companies for Intrinsic Value: Projected FCF. This places Ramsay Health Care in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 1.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Healthcare Providers & Services company?
The median Intrinsic Value: Projected FCF among Healthcare Providers & Services companies is 1.08, based on 342 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Ramsay Health Care and its competitors. For the Healthcare Providers & Services industry, the median Intrinsic Value: Projected FCF is 1.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Health Care's current Intrinsic Value: Projected FCF is A$43.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (ASX:RHC) is currently considered Modestly Overvalued. The stock's GF Value™ is A$40.77, compared to a current price of A$52.29 — trading 28.3% above its estimated fair value. The current Intrinsic Value: Projected FCF is A$43.83. Ramsay Health Care's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Ramsay Health Care (ASX:RHC), the current Intrinsic Value: Projected FCF is A$43.83 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Health Care (ASX:RHC) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Health Care stock appears to be overvalued.
The current stock price of A$52.29 is trading 28.3% above its estimated GF Value™ of A$40.77.
GuruFocus considers Ramsay Health Care to be Modestly Overvalued.
Key valuation signals for ASX:RHC:
Intrinsic Value: Projected FCF: A$43.83
GF Value™: A$40.77 vs. price of A$52.29 (28.3% above fair value)
No single metric tells the full story. See the ASX:RHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
80GF Score
Get the complete analysis for ASX:RHC
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHC has been successfully added to your 
